NEW MJ NEWS

HEXO to Begin Trading on the Nasdaq

HEXO Corp (“HEXO” or the “Company”) (TSX: HEXO; NASDAQ: HEXO) today announced that the previously announced transfer of its stock exchange listing to the Nasdaq Capital Market (“Nasdaq”) from the New York Stock Exchange is complete.

The Company’s common share will begin trading as a Nasdaq-listed security at market open today, August 24, 2021. Current retail and institutional investor shares will automatically be transferred over to Nasdaq. Current shareholders are not required to take any action.

About HEXO

HEXO is an award-winning licensed producer of innovative products for the global cannabis market. HEXO serves the Canadian recreational market with a brand portfolio including HEXO, UP Cannabis, Original Stash, Bake Sale, Namaste, and REUP brands, and the medical market in Canada, Israel and Malta. The Company also serves the Colorado market through its Powered by HEXO® strategy and Truss CBD USA, a joint venture with Molson Coors. In the event that the previously announced transactions to acquire 48North and Redecan close, HEXO expects to be the number one cannabis products company in Canada by recreational market share.

For more information, please visit www.hexocorp.com.

Investor Relations:

invest@HEXO.com

www.hexocorp.com

Media Relations:

(819) 317-0526

media@hexo.com


MAPH Enterprises, LLC | (305) 414-0128 | 1501 Venera Ave, Coral Gables, FL 33146 | new@marijuanastocks.com
Leave a Reply

Your email address will not be published. Required fields are marked *

You May Also Like

TerrAscend Corp. (TRSSF) to host second quarter 2021 investor conference call

TerrAscend to host second quarter 2021 investor conference call TerrAscend Corp. (“TerrAscend”…

 The Green Organic Dutchman Holdings Ltd. (TGOD) (TGODF) Signs Arrangements for Up to $103 Million in Funding

The Green Organic Dutchman Signs Arrangements for Up to $103 Million in…

 Aphria Inc. (APHA) Announces Receipt of EU GMP Certification

Aphria Inc. Announces Receipt of EU GMP Certification for Subsidiary ASG Pharma…